TP53 and cancer: The most active compounds of this type have shown cytotoxicity in the 4–11 μm range on cancer cell lines HepG2, MCF-7, SiHa and HCT116, [23], and some p53 activation by Western blotting (see Supplementary Information, Figure S1).